Trials / Unknown
UnknownNCT02342158
Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors
Identifying Molecular Alterations to Guide Individualized Treatment in Advanced Solid Tumors-PERMED01-IPC 2014-003
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 550 (actual)
- Sponsor
- Institut Paoli-Calmettes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
PERMED01 is a prospective monocenter clinical trial which aims to evaluate the number patients with locally advanced or metastatic cancer for whom identification of molecular alterations in tumor samples can lead to the delivery of a targeted therapy. PERMED01 will enroll 460 patients in 3 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | biopsy or surgical sampling | |
| OTHER | blood sampling |
Timeline
- Start date
- 2014-11-12
- Primary completion
- 2020-06-01
- Completion
- 2022-11-01
- First posted
- 2015-01-19
- Last updated
- 2021-01-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02342158. Inclusion in this directory is not an endorsement.